This patent teaches the in vivo expansion of neural stem cells through administration of fibroblast growth factor in combination with an agent selected from the group comprising of: EGF, TGF, and amphiregulin.
This patent is useful for the treatment of degenerative nervous system diseases alone, or in combination with exogenously administered stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.